Stock Repurchase Program	9 Months Ended
Jul. 31, 2019
Equity [Abstract]
Stock Repurchase Program	Note 9. Stock Repurchase Program As discussed in the Company’s Annual Report on Form 10-K filed on December 19, 2018, on March 20, 2018 the Company’s Board of Directors authorized up to $50.0 million of repurchases of the Company’s issued and outstanding common stock with an expiration date of March 19, 2020. On September 5, 2018 the Company’s Board of Directors authorized an additional $50.0 million of repurchases of the Company’s issued and outstanding common stock with an expiration date of September 4, 2020. During the three months ended July 31, 2019, the Company repurchased 222,122 shares under this repurchase program at a total cost of $3.0 million and an average price per share of $13.53. During the nine months ended July 31, 2019, the Company repurchased 717,597 shares under this repurchase program at a total cost of $8.3 million and an average price per share of $11.62. As of July 31, 2019, the Company had $38.3 million of authorization remaining under this program.

Stock Repurchase Program

9 Months Ended

Jul. 31, 2019

Note 9. Stock Repurchase Program

As discussed in the Company’s Annual Report on Form 10-K filed on December 19, 2018, on March 20, 2018 the Company’s Board of Directors authorized up to $50.0 million of repurchases of the Company’s issued and outstanding common stock with an expiration date of March 19, 2020. On September 5, 2018 the Company’s Board of Directors authorized an additional $50.0 million of repurchases of the Company’s issued and outstanding common stock with an expiration date of September 4, 2020. During the three months ended July 31, 2019, the Company repurchased 222,122 shares under this repurchase program at a total cost of $3.0 million and an average price per share of $13.53. During the nine months ended July 31, 2019, the Company repurchased 717,597 shares under this repurchase program at a total cost of $8.3 million and an average price per share of $11.62. As of July 31, 2019, the Company had $38.3 million of authorization remaining under this program.